Appendix 4D, Half-year report of 30th June, 2019, has been lodged with the Australian Securities Exchange.
View Appendix 4D Half-year report.
Positive independent review sets priority path to market for MagSense® Technology
Highlights Blinded review by panel of expert breast radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance